U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06937619) titled 'A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants' on April 04.
Brief Summary: This study will assess the pharmacokinetics and relative Bioavailability of risankizumab following subcutaneous (SC) administration with on-body Injector in Healthy Adult Participants.
Study Start Date: April 12
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: Risankizumab
Subcutaneous Injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health...